Yungjin Pharm Co Ltd (003520) — Cash Flow Reinvestment Rate
Yungjin Pharm Co Ltd (003520) has a Cash Flow Reinvestment Rate of 0.61x as of September 2025, reinvesting ₩4.28 Billion (capex ₩2.16 Billion plus investments ₩-2.12 Billion) from operating cash flow of ₩7.00 Billion. Check how high is Yungjin Pharm Co Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Yungjin Pharm Co Ltd Cash Flow Reinvestment Rate (2013–2024)
Historical reinvestment intensity for Yungjin Pharm Co Ltd across 10 annual periods. Explore 003520 long-term investments to assets to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Yungjin Pharm Co Ltd (2013–2024)
Year-by-year capital reinvestment analysis for Yungjin Pharm Co Ltd. For live market cap and broader valuation context, see Yungjin Pharm Co Ltd market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.13x | ₩24.61 Billion | ₩21.74 Billion | ₩21.61 Billion | ▼ -19.9% |
| 2021 | 1.41x | ₩11.82 Billion | ₩8.37 Billion | ₩11.32 Billion | ▲ +71.3% |
| 2020 | 0.82x | ₩11.96 Billion | ₩14.50 Billion | ₩6.30 Billion | ▼ -63.0% |
| 2019 | 2.23x | ₩20.69 Billion | ₩9.28 Billion | ₩10.36 Billion | ▼ -61.3% |
| 2018 | 5.76x | ₩7.34 Billion | ₩1.27 Billion | ₩4.71 Billion | ▲ +9.4% |
| 2017 | 5.26x | ₩16.59 Billion | ₩3.15 Billion | ₩10.59 Billion | ▲ +240.9% |
| 2016 | 1.54x | ₩4.81 Billion | ₩3.11 Billion | ₩4.69 Billion | ▼ -10.4% |
| 2015 | 1.72x | ₩15.16 Billion | ₩8.80 Billion | ₩13.75 Billion | ▼ -6.1% |
| 2014 | 1.84x | ₩11.41 Billion | ₩6.22 Billion | ₩11.30 Billion | ▲ +38.1% |
| 2013 | 1.33x | ₩7.91 Billion | ₩5.95 Billion | ₩6.63 Billion | — |